International Society for Heart and Lung Transplantation (ISHLT) 36th Annual Meeting and Scientific Sessions
In-Person EventApr 27 - 30, 2016Washington, Dist Of Col, USA
Speakers
OVERVIEW
The International Society for Heart
and Lung Transplantation is a leading
organization providing education for
medical professionals involved in
heart and lung transplantation. Because
of the rapid advances in medicine
in general and transplantation
medicine specifically, transplant
professionals are in need of regular
opportunities to update and maintain
their knowledge of advances
and changes in transplant medicine.
This meeting is designed to address
their needs.
The educational goals of this activity
are: to enable participants to learn
about current practices, emerging
technologies and medical advances
related to heart and lung transplantation
and end-stage heart and lung
disease and to provide a forum for
participants to engage in discussion,
debate, and examination regarding
the efficacy and applicability of these
current practices, emerging technologies
and medical advances.
Learning Objectives:
1. At the conclusion of this meeting, participants will have improved competence and professional performance
in the areas of understanding the latest information and approaches regarding transplant research, surgical
techniques, medical therapies, donor management, and patient management for the treatment of patients
suffering from end stage heart and lung disease
2. At the conclusion of this meeting, participants will have improved competence and professional performance
in the areas of understanding the state-of-the-art treatment approaches, risk factors, risk management approaches,
patient selection criteria, disease prevention strategies, outcome implications, and psychosocial management
strategies for patients with end stage heart and lung failure.
3. At the conclusion of this meeting, participants will have improved competence and professional performance
in the areas of understanding emerging technologies, medical advances, and the clinical applications of basic
science models of end stage heart and lung disease management and prevention.